The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
Recent Study on How Physical Activity May Boost Neurocognition in Late Adulthood Featured in the Medical Journal Age and Ageing
-
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
-
Transforming lives of stroke survivors: AdventHealth, Orlando Neurosurgery first in nation to perform 50 Vivistim implant cases
-
AdventHealth Involved in Research to Evaluate First Potential Disease-Modifying Treatment for Epileptic Patients with Dravet Syndrome
-
AdventHealth Neuroscience Institute Secures New Gamma Knife Radiosurgery Platform to Advance Patient Care
-
Leading Health Systems Join Pioneering Effort to Improve Alzheimer’s Diagnosis
-
Unlocking the Secrets of Healthy Aging: How AdventHealth Scientists are Researching the Connection Between Exercise and Brain Health
-
AdventHealth Scientists Help Develop Blood Test That Detects Indicator of Parkinson’s Disease